Tests of the CarnaLife System application in Medicover Poland yield very good results.
Medicover Polska facilities are testing the CarnaLife System application for remote patient health monitoring. MedApp S.A. software cares for chronically ill patients with diabetes and cardiac problems treated in selected Warsaw facilities of our partner.More
Science fiction becomes reality with technologies developed by the publicly traded company MedApp
Using MedApp’s unique CarnaLife Holo technology, we obtained holographic images of the inside of the heart, which we used to perform a minimally invasive mitral valve repair procedure without opening the chest, using the MitraClip system.More
Pre-operative surgical planning to remove the liver and pancreatic cancer lesions using CarnaLifeHolo technology!
We invite you to see the video report and hear the doctors’ opinions after the procedure.More
East Value Research Analyst Report
An independent analyst report prepared by analysts at East Value Research was released today.More
MedApp one of the TOP15 European medtech startups, multiplied revenues and profits
MedApp, a Kraków-based company, recorded close to PLN 3.7 million in revenues between July and September this year, which is almost 4 times more than a year ago. EBITDA in Q3 2021 amounted to PLN 1.6 million (almost 10 times more than last year), and net profit increased by more than PLN 1.4 million (31 times higher yoy).More
CarnaLife System will enable remote monitoring of patients of the TeleMed24 Operations and Support Center
With the cooperation established between MedApp S.A. and MKW S.A., the owner of the TeleMed24 brand, patients under the care of the Bytom facility will gain access to full, remote monitoring and diagnostics of heart and circulatory system diseases based on the CarnaLife System platform solutions.More
MedApp continues global expansion and launches operations in the Brazilian market
The signed agreement covers the sale of the CarnaLife Holo technology. In the coming week, training sessions for our distributor’s representatives in Brazil are starting. We expect that before the end of the year, the first demonstration treatments using CarnaLife Holo in Brazilian hospitals will be possible.More
MedApp S.A., is the partner of the nationwide contest for schoolgirls “Become an Ambassador”.
On October 11, 2021, in celebration of the International Day of the Girl, 12 finalists of the nationwide contest for schoolgirls “Become an Ambassador” were given the opportunity to learn about the world of diplomacy by playing the role of an Ambassador in one of the participating Embassies.More
Google selects MedApp S.A. as one of the fifteen best MedTech startups in Europe
Google Accelerator is an initiative of the US giant to support the most promising technology projects. In the current edition, the Google Accelerator has focused on technologies that solve problems in modern medicine, healthcare and improving patient well-being.More
MedApp is one of three finalists of the Start-up Challenge 2021 in the category Health and Biotechnology during the European Economic Congress in Katowice
On 21 September 2021, the founders and leaders of the most interesting Polish and European start-ups stood on the stage of the European Economic Congress for the sixth time. Among them, in the category HEALTH & BIOTECHNOLOGY: medicine, health, medical technology, pharmacy, biotechnology was MedApp S.A.More
The results generated in H1 2021 by MedApp S.A. are similar to the results the Company achieved for the whole of 2020. The interview with Krzysztof Mędrala, CEO of MedApp S.A.
In connection with the publication of the Interim Report for Q2 2021 on September 12, 2021, we invite you to watch the interview with Krzysztof Mędrala, CEO of MedApp S.A. according to Company’s activities realized in the reporting period and the financial results achieved in H1 2021.More
MedApp significantly increases its business scale in Q2 2021.
The Cracow-based company, offering innovative technological solutions in medicine (medtech), achieved a net result in the first half of this year, similar to the level for the whole of last year.More
New company address
We are pleased to inform you about the new address. From today, we are available at Armii Krajowej 25, 30-150 Krakow, Poland.More
Minority Shareholders of MedApp S.A. obtained representation in the Supervisory Board of the Company
During the Annual General Meeting held on June 29, the Shareholders of MedApp S.A. decided to appoint Mr. Bogusław Bodzioch to the Supervisory Board.More
MedApp S.A. in collaboration with Microsoft are extending the functionality of the CarnaLife System platform by making Microsoft Teams available to patients and medical staff
MedApp, the creator of the proprietary CarnaLife System platform for remote diagnosis and monitoring of patients’ health, has expanded cooperation with its existing partner, Microsoft. Access to Microsoft Teams gives patients and physicians using CarnaLife System another convenient and simple tool to communicate during medical consultations.More
OPERATION HOLOGRAM – CarnaLife Holo, or technology that will blow your mind!
What can Dr. Maciej Kawecki and Filip Chajzer say about our revolutionary CarnaLife Holo technology for 3D medical data visualization? What does surgery for a rare cancer using a hologram look like? How does the latest technology save lives? How does it work? For the curious, we recommend an episode of “W głowie się nie mieści!” to answer these questions!More
MedApp S.A. partnerem profilaktycznej akcji onkologicznej – ONKOODPOWIEDZIALNI
The “Onkoodpowiedzialni” campaign dedicated to oncology education, prevention and health promotion has been launched.More
MedAppS.A. strengthens its distribution network in Poland by signing a contract worth nearly EUR 6 million
MedApp, a medtech company that offers solutions based on artificial intelligence, mixed reality, and 3D modeling and imaging, among other things -is strengthening its distribution network.More
In connection with the publication of the Interim Report for Q1 2021 on May 14, 2021, we invite you to watch an investor meeting with Krzysztof Mędrala, CEO of MedApp S.A.
The meeting on May 17, 2021 was held by the Polish Association of Individual Investors. We would like to thank Michal Maslowski for the engaging conversation. We appreciate the presence of Investors and Partners interested in our results in the first months of this year and the Company’s plans for the next quarters of 2021.More
MedApp S.A. launches cooperation with Medicover Polska in the area of digital medicine
MedApp, a NewConnect-listed company operating in the medtech segment, has established cooperation with Medicover Poland, a nationwide medical network. As part of the cooperation, the Company will pilot CarnaLife System, digital medicine solution for remote patient health monitoring and treatment management, in selected medical centers.More
How is the results of the 1st quarter of 2021 assessed by the Management Board of MedApp S.A.?
MedApp S.A. has achieved very good financial results. We obtained revenues of PLN 1,944,000 and a net result of PLN 376,000. This is another very good quarter in which the Company achieves positive financial results.More
MedAppS.A. reports favorable results for the first quarter of 2021
MedApp, a NewConnect-listed company operating in the medtech segmentand offering solutions based on, among others, artificial intelligence, mixed reality and 3D imaging, in the first quarter of 2021 achieved net sales revenues of PLN 1,944,000, which means a continuation of the dynamic growth insales revenues and profits from the end of last year.More
MedApp S.A. starts distribution in France
MedApp, a company offering unique software solutions to support diagnostic imaging and new generation digital medicine services, is expanding its presence in Europe by introducing CarnaLife Holo in France and Luxembourg thanks to a distribution agreement with its French partner FP Business SAS.More
MedApp recaps 2020. Record financial results and intensive portfolio commercialization
MedApp, a NewConnect-listed technology company whose innovative solutions for diagnostic imaging and digital medicine are revolutionizing the way people are treated, successfully closes out the past year. In 2020, the Company achieved record financial results, reporting an 87-percent increase in revenue and a 185-percent increase in net income over the previous year.More
MedApp S.A. participates in Living Lab: a program for developers of innovative digital services and solutions
MedApp, a technology company developing unique solutions to support diagnostic imaging and next-generation digital medicine services, has been selected for NEO Hospital Group’s Living Lab program, which targets developers of innovative digitalservices and solutions.More
MedApp to implement StethoMe in its app
MedApp has signed an agreement with StethoMe, a start-up developer of a solution for remote detection of respiratory abnormalities. As part of the partnership, MedApp’s digital medicine application will support a wireless stethoscope. The new device will expand the range of tests offered by medical facilities using CarnaLife System and Digital Clinic solutions.More
MedApp’s record results in 2020
MedApp, a NewConnect-listed technology company developing innovative solutions for diagnostic imaging and digital medicine, has released its estimated results for the past year. In 2020, the company’s revenue reached PLN 6,036,000 and increased by 187% compared to 2019 (PLN 3,226,000). In addition, in 2020, MedApp generated a net profit of PLN 2,070,000, an increase of 308% compared to 2019 (PLN 673,000).More
MedApp’s record results in 2020More
MedApp S.A. starts cooperation with Diagnostyka, a nationwide chain of medical laboratories
MedApp S.A. signed a partnership agreement for a new Digital Clinic service with Diagnostyka, the largest Polish chain of medical laboratories. Thanks to the cooperation, patients and doctors will have easier access to the tests performed by Diagnostyka and secure insight into their results in electronic form -via a computer or a mobile app.More
NEO Hospital to use innovative MedApp technologies as part of a research and development project
MedApp S.A. has strengthened its cooperation with NEO Hospital Group. As part of the signed agreement, the Group’s Szpital na Klinach will use the CarnaLife Holo technology for 3D visualization of imaged medical data in the implementation of a newresearch and development project. Its goal is to develop a new method for the surgical treatment of endometrial and cervical cancers.More
MedApp enters into an insurance agreement with Chubb European Group SE, beginning expansion into new foreign markets
MedApp has just signed an insurance agreement with Chubb European Group SE, Branch in Poland, for the implementation of activities in thearea of information technology related to healthcare. For the company, which develops innovative 3D holographic imaging technologies, used e.g. in cardiology, oncology and orthopedic procedures (CarnaLife Holo) and in the education of medical staff (SurgeonEye), as well as next-generation digital medicine solutions, this is a major step in expanding into foreign markets.More
MedApp expands partnership with Microsoft
MedApp is expanding its partnership with Microsoft. The Company has just obtained Mixed Reality DMP status with the tech giant, making it the official distributor of its mixed reality holographic visualization device, HoloLens 2. MedApp already holds Silver Partner status in the MRPP program and also offers a Microsoft Azure cloud solution to its clients.More